WHO has made available the membership of the Guidelines Development Group (GDG) for the Living recommendations and systematic reviews for the WHO Screening and Treatment Recommendations to Prevent Cervical Cancer. The plan is to develop recommendations for screening and treatment to prevent cervical cancer in women living with and without HIV based
on current evidence for the benefits and harms and for other criteria important to decision making and implementation.
The specific objectives are to
- map current recommendations for screening and treatment strategies to prevent cervical cancer in an electronic platform to identify gaps and to track all recommendations for screening and treatment strategies to prevent cervical cancer;
- identify living and static recommendations according to the speed at which new evidence is being produced, and
- continuously produce and publish recommendations as new evidence becomes available within a system where other recommendations are updated every 3-5 years.
The group will meet in a series of meetings, with the first planned from 6 to 7 December 2022 (hybrid), followed by virtual meetings every 8 to 12 weeks. The Guideline Development Group will determine recommendation questions for which the evidence should be actively monitored over the next 1 to 3 years, to decide whether information found through monitoring necessitates a full systematic review; and to make recommendations.
In line with WHO policy on conflict of interest, members of the public and interested organizations can access the biographies of the GDG members and inform WHO of their views about them. All comments should be sent by email to srhsrc@who.int by 2 December 2022.